12 Health Care Stocks Moving In Tuesday's After-Market Session
GainersReshape Lifesciences (NASDAQ:RSLS) shares rose 88.9% to $0.39 during Tuesday's after-market session. The market value of their outstanding shares is at $9.2 million. Dermata Therapeutics (NASDA
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersAkanda (NASDAQ:AKAN) shares rose 177.7% to $0.37 during Friday's pre-market session. The company's market cap stands at $11.7 million. Scorpius Holdings (AMEX:SCPX) stock increased by 28.17% to
Reneo Pharmaceuticals And 2 Other Stocks Under $2 Insiders Are Buying
The Dow Jones index closed lower by around 0.1% on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders inter
Reneo Pharmaceuticals Insider Bought Shares Worth $639,578, According to a Recent SEC Filing
Braden Michael Leonard, 10% Owner, on May 14, 2024, executed a purchase for 414,281 shares in Reneo Pharmaceuticals (RPHM) for $639,578. Following the Form 4 filing with the SEC, Leonard has control o
Reneo Pharmaceuticals(RPHM.US) 10% Shareholder Buys US$639.58K in Common Stock
$Reneo Pharmaceuticals(RPHM.US)$ 10% Shareholder Leonard Braden Michael purchased 414.28K shares of common stock on May 14, 2024 at an average price of $1.54 for a total value of $639.58K.Source: Anno
Express News | HC Wainwright & Co. Reiterates Neutral on Reneo Pharmaceuticals, Maintains $1.5 Price Target
Reneo Pharmaceuticals Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/14/2024 -3.23% HC Wainwright & Co. → $1.5 Reiterates Neutral → Neutral 12/15/2023 -3.23% HC Wainwright
Mitchell Kapoor's Hold Rating on Reneo Pharmaceuticals Amid OnKure Merger and Oncology Pipeline Potential
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Reneo Pharmaceuticals, Inc. Merger
Wilmington, Delaware--(Newsfile Corp. - May 13, 2024) - Rigrodsky Law, P.A. is investigating Reneo Pharmaceuticals, Inc. ("Reneo") (NASDAQ: RPHM) regarding possible breaches of fiduciary duties and ot
What's Going On With Reneo Pharmaceuticals Stock Today?
Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) shares initially traded higher Monday before turning negative after the company announced a proposed merger with OnKure, Inc.The Details: Reneo and Onkure ann
Shareholder Alert: Ademi LLP Investigates Whether Reneo Pharmaceuticals, Inc. Has Obtained a Fair Price in Its Transaction With OnKure
MILWAUKEE, May 13, 2024 /PRNewswire/ -- Ademi LLP is investigating Reneo (Nasdaq: RPHM) for possible breaches of fiduciary duty and other violations of law in its going private transaction with OnKur
Express News | Reneo Pharmaceuticals Inc - Combined Co Is Expected to Have Approximately $120 Mln of Cash, Cash Equivalents, and Short-Term Investments at Closing
Express News | Reneo Pharmaceuticals Inc - Merger Agreement Provides That Board of Directors of Combined Company Will Be Composed of Eight Members
Express News | Reneo Pharmaceuticals Shares Are Trading Higher After the Company Entered a Merger Agreement With OnKure
Express News | Reneo Pharmaceuticals Inc - Combined Company Will Be Led by Nicholas Saccomano, President & CEO of Onkure
Reneo-OnKure Combined Co. Expected To Have ~$120M Of Cash, Cash Equivalents And Short-Term Investments At Closing
Reneo-OnKure Combined Co. Expected To Have ~$120M Of Cash, Cash Equivalents And Short-Term Investments At Closing
Express News | Reneo Pharmaceuticals And OnKure Enter Definitive Merger To Combine In All-Stock Transaction; Reneo Stockholders Expected To Own ~31%, OnKure Shareholders To Own ~69%, Expected To Close In 2024
Express News | Reneo Pharmaceuticals: Pre-Merger Reneo Stockholders to Own About 31% of Combined Co, Pre-Merger Onkure Stockholders to Own About 69% of Combined Co
Express News | Reneo Pharmaceuticals- Entered Into Subscription Agreement for $65 Mln Private Investment in Public Equity (Pipe) Financing
Reneo Pharmaceuticals, OnKure In Definitive Merger Agreement to Combine Companies in an All-Stock Transaction >RPHM
Reneo Pharmaceuticals, OnKure In Definitive Merger Agreement to Combine Companies in an All-Stock Transaction >RPHM